Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
September 18, 2017 – Symbiomix Therapeutics announced the FDA approval of Solosec (secnidazole), for the treatment of bacterial vaginosis (BV) in adult women.
